Drug Profile
PL 201
Alternative Names: PL201Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Polyrizon
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in HIV-infections(Prevention) in Israel (Vaginal, Gel)